substantial and unique platform..., page-5

AcesHigh...

Some good dialogue there mate...but probably over the heads of many, which may explain the lack of response?

And you are spot on with the ultimate measure of value...far too many try to do so based on rigid, straight line comparisons with other Companies (drug x compared to drug y, etc)...this is simply not possible beyond wide ranging generalisations given the multitude of parameters effecting market value of any product line, or indeed the entities driving them.

When discussing peer comparisons in any industry, we need to be careful to do so using broad-stroke, approximate analysis only...with obvious consideration of their respective products, but more importantly, based on the corporate architecture put in place to commercialise them

So...all we really can do is compare perceived "value" given their current progress within their specific market, using the sort of value markers that remain relatively consistent in all industries and all corporations (more on this another day)...then weigh all of this against the likelihood of "corporate success" and what this means for future revenues within the specific sector.

No wonder the market gets these wrong most of the time...and more often than not require a hit to the face in the form of tangible developments (typically via an announcement), that often reveal the inherent value that existed all along, but that everyone was missing.

As you suggest...we are likely to get something along these lines for ANP in the near future which should, in my view, underline for the market the hidden value ANP are currently sitting on.

Happens all the time...and doesn't matter what sector...the effects are the same.

We saw what happened to PRR (lifting it from 1c to over 40c at one stage - currently 17.5c)...and a similar thing happened to SSN where the market was happy to sell it down at a perceived "fair value" of between 1-2c, placing a market cap of between $15m - $30m or so on that stock at the time...then out of left field comes a payment of $75m or so for part of just one of their assets?

The stock eventually rose (was still slow in the uptake initially), going as high 23c once the rally set-in, which lifted the market cap to well over $300m. Today they are still happily holding a market cap ranging in the $170-200m range.

This change in "value" was not the result of a new discovery, or change in circumstance in any way that suddenly added value to their assets (product), it was simply a result of the sudden awareness by the market of the true underlying value that was always there...now realised by a tengible development...but had simply been missed by the market!

In my experience, the market is nearly always wrong in equating value...which is just as well, as it provides the main driver of opportunity (and profit) for me!

Cheers!